Feature | August 27, 2012

Study Shows CT is Superior for Indicating Cardiovascular Risk

A new? study indicates the CT coronary artery calcium score is the superior test for accurately predicting cardiovascular risk and disease in adults at intermediate risk for heart disease

August 27, 2012 - A recent multi-center study, led by researchers from Wake Forest School of Medicine and published in the Journal of the American Medical Association (JAMA) has indicated that computed tomography (CT) scanning of the heart and measuring the coronary artery calcium (CAC) score is the most accurate predictor of cardiovascular disease for individuals at intermediate risk for heart disease.

The study included 1,300 individuals with intermediate cardiovascular risk factors (excluding diabetes) based on the Framingham Risk Score (FRS), who were followed over a period of seven years as part of the National Heart, Lung and Blood Institute's Multi-Ethnic Study of Atherosclerosis (MESA). MESA is an observational study of cardiovascular disease performed at six sites across the United States.
Six novel or established markers of heart disease risk were directly compared. These included the CT CAC score, ankle-brachial index, brachial flow mediated dilation, carotid intima-media thickness, high sensitivity C-reactive protein and family history of heart disease. CAC score, determined by CT scan, held the highest predictive association for cardiovascular disease.
According to Jeffery J. Carr, M.D., MSc, a co-author on the publication and president-elect of the Society of Cardiovascular Computed Tomography (SCCT), "This work demonstrates that the calcium score outperforms these widely studied tests and even family history in the prediction of future heart attacks and cardiovascular death. For healthcare providers, we have the first direct comparison of these tests. This new evidence will help in advising our patients when additional information is needed to refine an individual's risk of heart disease. In many cases, no additional testing is needed; however, for those important cases where refining our understanding of risk of heart disease is critical to medical decision-making, the cardiac CT measured calcium score is a clear winner as relates to future risk for an individual."
Although CAC scans indicated the highest level of accuracy in predicting cardiovascular risk, factors such as cost and the level of risk due to radiation exposure from CT scan will be future considerations in research.
For more information, visit www.SCCT.org

Related Content

St. Jude Medical, ADO II AS trial, congenital heart disease, PDA, Amplatzer Duct Occluder II AS
News | Congenital Heart| October 19, 2016
St. Jude Medical Inc. announced the launch of the ADO II AS (AMPLATZER Duct Occluder II Additional Sizes) pediatric...
Lantheus, flurpiridaz F-18, myocardial perfusion imaging, MPI, cardiac stress testing, ASNC 2016
News | Radiopharmaceuticals and Tracers| October 17, 2016
Lantheus Holdings Inc. announced in late September that sub-analysis data from the first Phase 3 study of flurpiridaz F...
Medtronic, FIRE AND ICE trial, Arctic Front, cryoballoon catheter ablation, radiofrequency RF ablation, study results, Asia Pacific Heart Rhythm Society Scientific Sessions
News | Ablation Systems| October 17, 2016
Medtronic plc last week unveiled new health economic analysis data from the FIRE AND ICE trial that favor cryoballoon...
Toshiba CT, picking a CT scanner, choosing a CT scanner, CT 101, what to look for in CT scanners, Aquilion ONE ViSION

The Toshiba Aquilion One Vision system is among the new generation of CT systems on the market that offers several dose lowering technologies and a hardware/software combination to enhance image quality over previous-generation scanners.

Feature | CT Angiography (CTA)| October 14, 2016 | Dave Fornell
As hospitals begin replacing their first-generation 64-slice computed tomography (CT) scanners after a decade of use,
transcarotid artery revascularization, TCAR Surveillance Project, Society for Vascular Surgery Patient Safety Organization, SVS PSO,
News | Stents Carotid| October 13, 2016
A surveillance project to evaluate the safety and effectiveness of transcarotid artery revascularization (TCAR) in...
Shockwave lithoplasty system, VIVA 16, Vascular Interventioanl Advances, VIA Physicians, late-breaking endovascular clinical trial results
News | Cath Lab| October 12, 2016
VIVA (Vascular Interventional Advances) Physicians announced a number of highly anticipated late-breaking clinical...
ZipLine Medical, Zip Surgical Skin Closure, cath lab time savings, PACE study
News | EP Lab| October 10, 2016
October 10, 2016 — ZipLine Medical Inc.
Mercator MedSystems, Bullfrog Micro-Infusion Device, DANCE trial, VIVA 2016, 13-month results
News | Peripheral Arterial Disease (PAD)| October 07, 2016
Mercator MedSystems recently announced that 13-month data from the DANCE trial was presented during a late-breaking...
Keystone Heart, TriGuard Embolic Protection Device, Neuro-TAVR study, brain lesions, American Journal of Cardiology
News | Heart Valve Technology| October 03, 2016
Keystone Heart Ltd. announced data recently published in the American Journal of Cardiology demonstrating new brain...
TCT 2016, TCT.16, main arena, late breaking trials
Feature | Cath Lab| September 28, 2016
September 28, 2016 — The Cardiovascular Research Foundation (CRF) has announced the 11 late-breaking trials and 16 fi
Overlay Init